Advertisement
Screener

VERICEL CORPORATION (VCEL) Cash Flow Breakdown

VERICEL CORPORATION Cash Flow Breakdown

Cash flow breakdown shows where VERICEL CORPORATION's cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2026-06-30: from running the business, $69.67M came in.
  • Fiscal year ended 2026-06-30: from investing, $26.79M went out.
  • Fiscal year ended 2026-06-30: from financing, $1.94M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingDebt paid backNew debtCommercial paperStaff share taxNew shares soldOtherNot split outChange in cash
2026-06-30$69.67M*-$26.79M*-$5.14M*$7.16M*-$76.00K*
2025-12-31$51.91M-$43.94M-$6.82M$13.93M-$47.00K$15.04M
2025-06-30$47.24M*-$60.03M*-$6.77M*$24.25M*-$15.00K*
2024-12-31$58.16M-$79.03M-$5.46M$24.52M$0.00-$1.82M
2024-06-30$42.99M*-$46.69M*-$5.20M*$13.96M*-$21.00K*
2023-12-31$35.31M-$3.13M-$2.34M$6.00M-$41.00K$35.80M
2023-06-30$29.13M*-$22.15M*-$2.23M*-$41.00K*$3.86M*
2022-12-31$17.69M-$36.21M-$1.49M$3.65M-$39.00K-$1.08M*-$17.47M
2022-06-30$20.80M*-$14.41M*-$1.54M*$5.77M*-$350.00K*
2021-12-31$29.04M-$3.50M-$1.67M$11.18M-$348.00K$34.71M
2021-06-30$30.76M*-$45.87M*-$1.56M*$12.88M*-$30.00K*
2020-12-31$17.57M-$17.16M$0.00-$163.00K$6.63M-$28.00K$6.85M
2020-06-30$12.71M*$24.72M*-$163.00K*$4.60M*-$31.00K*
2019-12-31-$7.18M$10.62M$0.00$0.00$0.00$5.29M-$26.00K$8.69M
2019-06-30-$13.60M*-$54.20M*$4.32M*$20.00K*-$17.55M*
2018-12-31-$412.00K-$67.03M-$17.53M$0.00$4.36M$0.00$72.03M*-$8.58M
2018-06-30-$9.44M*-$2.22M*$10.18M*-$9.00K*$82.41M*
2017-12-31-$13.18M-$1.51M-$7.15M-$889.00K$8.22M$0.00$18.40M*$3.88M
2017-06-30-$22.27M*-$707.00K*-$39.00K*$27.22M*
2016-12-31-$19.89M-$1.42M-$38.00K-$2.40M$32.14M*
2016-06-30-$11.16M*-$1.85M*-$37.00K*$2.66M*
2015-12-31-$13.35M-$2.39M-$35.00K$0.00
2015-06-30-$23.26M*-$4.73M*-$19.00K*$41.02M*
2014-12-31-$25.41M-$2.18M-$8.00K$0.00$49.93M*
2014-06-30-$19.23M*$1.04M*-$19.00K*$20.98M*
2013-12-31-$19.94M-$40.00K-$34.00K$0.00*$0.00*$14.44M*
2013-06-30-$26.45M*-$227.00K*-$40.00K*$0.00*$0.00*$2.55M*
2012-12-31-$29.55M-$273.00K-$40.00K$37.97M*
2012-06-30-$26.84M*-$705.00K*-$124.00K*$37.81M*
2011-12-31-$24.49M-$1.03M-$227.00K
2010-06-30-$15.09M-$5.12M-$479.00K$17.80M*
2009-06-30-$13.80M$5.96M-$445.00K$8.79M*

Each quarter (3 month)

Quarter endRunning the businessFrom investingDebt paid backNew debtStaff share taxNew shares soldOtherNot split outChange in cash
2026-06-30$16.19M*-$2.82M*-$143.00K*$2.86M*-$23.00K*
2026-03-31$16.38M-$4.20M-$4.52M$1.56M-$21.00K$9.20M
2025-12-31$15.01M*-$16.39M*-$169.00K*$1.25M*-$21.00K*
2025-09-30$22.08M*-$3.38M*-$305.00K*$1.48M*-$11.00K*
2025-06-30$8.21M*-$9.03M*-$136.00K*$1.79M*-$11.00K*
2025-03-31$6.60M-$15.14M-$6.21M$9.41M-$4.00K-$5.34M
2024-12-31$22.24M*-$14.65M*-$153.00K*$7.26M*$0.00*
2024-09-30$10.18M*-$21.21M*-$271.00K*$5.79M*$0.00*
2024-06-30$18.54M*-$17.72M*-$138.00K*$4.43M*$0.00*
2024-03-31$7.20M-$25.45M-$4.90M$7.03M$0.00-$16.12M
2023-12-31$10.09M*-$8.09M*-$79.00K*$1.39M*$0.00*
2023-09-30$7.17M*$4.57M*-$86.00K*$1.12M*-$21.00K*
2023-06-30$10.20M*-$2.41M*-$79.00K*$1.27M*$1.00K*
2023-03-31$7.86M$2.80M-$2.10M$2.23M-$21.00K$10.77M
2022-12-31$6.97M*-$21.73M*-$7.00K*$612.00K*$0.00*
2022-09-30$4.10M*-$811.00K*-$44.00K*$829.00K*-$21.00K*
2022-06-30$3.14M*-$3.00M*-$498.00K*$746.00K*$1.00K*
2022-03-31$3.47M-$10.67M-$943.00K$1.47M-$19.00K-$6.70M
2021-12-31$10.55M*$1.89M*-$46.00K*$1.48M*-$96.00K*
2021-09-30$3.63M*-$2.63M*-$57.00K*$2.08M*-$236.00K*
2021-06-30$4.77M*-$14.94M*-$61.00K*$3.84M*$2.00K*
2021-03-31$10.09M$12.19M-$1.50M$3.78M-$18.00K$24.53M
2020-12-31$11.34M*-$25.68M*$0.00*$4.45M*$4.00K*
2020-09-30$4.57M*-$17.44M*$0.00*$809.00K*-$18.00K*
2020-06-30-$3.02M*$12.21M*-$66.00K*$953.00K*$3.00K*
2020-03-31$4.69M$13.74M-$97.00K$420.00K-$17.00K$18.73M
2019-12-31$3.15M*-$14.60M*$0.00*$1.52M*$3.00K*
2019-09-30$7.89M*$13.37M*$0.00*$1.70M*-$20.00K*
2019-06-30-$18.38M*-$3.81M*$0.00*$1.06M*$7.00K*
2019-03-31$154.00K$15.66M$0.00$998.00K-$16.00K$16.80M
2018-12-31$2.61M*-$20.45M*$1.05M*$23.00K*-$18.24M*
2018-09-30$2.01M*-$45.60M*$1.21M*$6.00K*$689.00K*-$41.68M*
2018-06-30-$5.44M*-$795.00K*$1.11M*-$11.00K*$70.33M*$65.19M*
2018-03-31$405.00K-$184.00K$985.00K-$18.00K$1.73M*$2.92M
2017-12-31$834.00K*-$718.00K*$671.00K*$252.00K*$10.36M*
2017-09-30-$5.24M*-$519.00K*$7.42M*-$232.00K*$1.43M*
2017-06-30-$5.65M*-$203.00K*-$10.00K*-$10.00K*-$5.81M*
2017-03-31-$3.12M-$70.00K-$10.00K-$3.13M
2016-12-31-$9.31M*-$101.00K*-$10.00K*$23.52M*
2016-09-30-$4.18M*-$333.00K*-$9.00K*$3.57M*-$955.00K*
2016-06-30-$5.13M*-$1.06M*-$10.00K*$2.50M*
2016-03-31-$1.27M$80.00K-$9.00K
2015-12-31-$4.04M*-$97.00K*-$9.00K*
2015-09-30-$718.00K*-$775.00K*-$9.00K*
2015-06-30-$4.48M*-$1.20M*-$8.00K*
2015-03-31-$4.11M-$318.00K-$9.00K
2014-12-31-$6.24M*-$646.00K*-$2.00K*
2014-09-30-$8.42M*-$2.57M*$0.00*$1.80M*$39.52M*
2014-06-30-$6.07M*$1.04M*-$2.00K*$14.00K*$3.45M*
2014-03-31-$4.67M$0.00-$4.00K$0.00*$5.29M$0.00*
2013-12-31-$4.34M*$0.00*-$4.00K*$0.00*$0.00*$1.59M*
2013-09-30-$4.14M*$0.00*-$9.00K*$0.00*$0.00*$10.47M*
2013-06-30-$4.70M*-$22.00K*-$10.00K*$0.00*$0.00*
2013-03-31-$6.76M-$18.00K-$11.00K$0.00*$0.00*$2.38M*
2012-12-31-$7.34M*-$104.00K*-$9.00K*$0.00*$0.00*
2012-09-30-$7.65M*-$83.00K*-$10.00K*$0.00*$0.00*
2012-06-30-$7.95M*-$4.00K*-$10.00K*$0.00*$0.00*
2012-03-31-$6.60M-$82.00K-$11.00K$37.90M*
2011-12-31-$6.14M*-$228.00K*-$45.00K*
2011-09-30-$6.14M*-$391.00K*-$58.00K*$0.00*$0.00*
2011-06-30-$5.79M*-$264.00K*-$60.00K*
2011-03-31-$6.42M-$148.00K-$64.00K

Similar stocks

Stock NameCountryMarket CapPE Ratio
RECURSION PHARMACEUTICALS, INC. (RXRX)United States$2.080B-3.78
Kodiak Sciences Inc. (KOD)United States$2.090B-10.12
ADMA BIOLOGICS, INC. (ADMA)United States$2.131B11.16
BIOCRYST PHARMACEUTICALS INC (BCRX)United States$2.175B-6.63
Vir Biotechnology, Inc. (VIR)United States$1.814B-6.85
NOVAVAX INC (NVAX)United States$1.748B-6.26
Hemab Therapeutics Holdings, Inc. (COAG)United States$1.672B
Greenland Mines Ltd (GRML)United States$2.362B
Immunocore Holdings plc (IMCR)$1.613B-90.43
Taysha Gene Therapies, Inc. (TSHA)United States$1.564B-14.80